1. Venkatesan P. GOLD report: 2022 update. Lancet Respir. Med. 2022; 10 (2): e20. https://doi.org/10.1016/S2213-2600(21)00561-0.
2. World Health Organization. World health statistics 2015. Geneva: WHO Press; 2023. Available at: https://www.who.int/publications/i/item/9789240694439
3. Çolak Y., Afzal S., Nordestgaard B.G. et al. Prevalence, characteristics, and prognosis of early chronic obstructive pulmonary disease. The Copenhagen General Population Study. Am. J. Respir. Crit. Care Med. 2020; 201 (6): 671-680. https://doi.org/10.1164/rccm.201908-1644OC.
4. Byanova K., Kunisaki K.M., Vasquez J., Huang L. Chronic obstructive pulmonary disease in HIV. Expert Rev. Respir. Med. 2021; 15 (1): 71-87. https://doi.org/10.1080/17476348.2021.1848556.
5. Kamenar K., Hossen S., Gupte A.N. et al. Previous tuberculosis disease as a risk factor for chronic obstructive pulmonary disease: a cross-sectional analysis of multicountry, population-based studies. Thorax. 2021; 77 (11): 1088-1097. https://doi.org/10.1136/thoraxjnl-2020-216500.
6. UNAIDS. Global HIV. AIDS statistics - Fact sheet 2023. Available at: https://reliefweb.int/report/world/global-hiv-aids-statistics-fact-sheet-2023 [Accessed: February 23, 2019].
7. Bagcchi S. WHO’s global tuberculosis report 2022. Lancet Microbe. 2023; 4 (1): e20. https://doi.org/10.1016/S2666-5247(22)00359-7.
8. Makinson A., Hayot M., Eymard-Duvernay S. et al. HIV is associated with airway obstruction: a matched controlled study. AIDS. 2018; 32 (2): 227-232. https://doi.org/10.1097/QAD.0000000000001691.
9. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease: 2024 Report. Available at: https://goldcopd.org/2024-gold-report
10. Singhvi D., Bon J., Morris A. Obstructive lung disease in HIV-phenotypes and pathogenesis. Curr. HIV/AIDS Rep. 2019; 16 (4): 359-369. https://doi.org/10.1007/s11904-019-00456-3.
11. Konstantinidis I., Crothers K., Kunisaki K.M. et al. HIV-associated lung disease. Nat. Rev. Dis. Primers. 2023; 9 (1): 39. https://doi.org/10.1038/s41572-023-00450-5.
12. Diaz P.T., King M.A., Pakht A. et al. Increased susceptibility to emphysema among HIV-seropositive smokers. Ann. Intern. Med. 2000; 132 (2): 369-372. https://doi.org/10.7326/0003-4819-132-5-200003070-00006.
13. Pérez-Padilla R. Would widespread availability of spirometry solve the problem of underdiagnosis of COPD. Int. J. Tuberc. Lung Dis. 2016; 20 (1): 4. https://doi.org/10.5588/ijtld.15.0893.
14. Maitre T., Cottenet J., Beltramo G. et al. Increasing burden of noninfectious lung disease in persons living with HIV: a 7-year study using the French nationwide hospital administrative database. Eur. Respir. J. 2018; 52 (3): 1800359. https://doi.org/10.1183/13993003.00359-2018.
15. Martinez F.J., Han M.K., Allinson J.P. et al. At the root: defning and halting progression of early chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2018; 197 (12): 1540-1551. https://doi.org/10.1164/rccm.201710-2028PP.
16. Agustí A., Noell G., Brugada J., Faner R. Lung function in early adulthood and health in later life: a transgenerational cohort analysis. Lancet Respir. Med. 2017; 5 (12): 935-945. https://doi.org/10.1016/S2213-2600(17)30434-4.
17. Lambert A.A., Kirk G.D., Astemborski J. et al. HIV infection is associated with an increased risk of exacerbation of COPD. J. Acquir. Immune Defic. Syndr. 2019; 69 (1): 68-74. https://doi.org/10.1097/QAI.0000000000000552.
18. Siddharthan T., Grigsby M., Morgan B. et al. Prevalence of chronic respiratory disease in urban and rural Uganda. Bull. World Health Organ. 2019; 97 (5): 318-327. https://doi.org/10.2471/BLT.18.216523.
19. Kayongo A., Wosu A.C., Naz T. et al. Chronic obstructive pulmonary disease prevalence and associated factors in a setting of well-controlled HIV, a cross-sectional study. COPD. 2020; 17 (3): 297-305. https://doi.org/10.1080/15412555.2020.1769583.
20. Brown J., Roy A., Harris R. et al. Respiratory symptoms in people living with HIV and the effect of antiretroviral therapy: a systematic review and meta-analysis. Thorax. 2017; 72 (4): 355-366. https://doi.org/10.1136/thoraxjnl-2016-208657.
21. Triplette M., Attia E., Akgun K. et al. The differential impact of emphysema on respiratory symptoms and 6-minute walk distance in HIV infection. J. Acquir. Immune Defic. Syndr. 2017; 74 (1): e23-29. https://doi.org/10.1097/QAI.0000000000001133.
22. De la Rosa Carrillo D., Olveira C., García-Clemente M. et al. COPD assessment test in bronchiectasis: minimum clinically important difference and psychometric validation: a prospective study. Chest. 2020; 157 (4): 824-833. https://doi.org/10.1016/j.chest.2019.08.1916.
23. Jones P.W., Brusselle G., Dal Negro R.W. et al. Properties of the COPD assessment test in a cross-sectional European study. Eur. Respir. J. 2011; 38 (1): 29-35. https://doi.org/10.1183/09031936.00177210.
24. Кравец С.Л., Ханин А.Л. Хроническая обструктивная болезнь легких у пациентов с легочным туберкулезом. В кн.: Медицина XXI века: сборник VI научно-практической конференции молодых ученых. Новокузнецк; 2016: 60-62.
25. Depp T.B., McGinnis K.A., Kremer K. et al. Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients. AIDS. 2016; 30 (3): 455-463. https://doi.org/10.1097/QAD.0000000000000940.
26. Ronit A., Lundgren J., Afzal S. et al. Airflow limitation in people living with HIV and matched uninfected controls. Thorax. 2018; 73 (5): 431-438. https://doi.org/10.1136/thoraxjnl-2017-211079.
27. Drummond M.B., Kirk G.D. HIV-associated obstructive lung diseases: insights and implications for the clinician. Lancet Respir. Med. 2014; 2 (7): 583-592. https://doi.org/10.1016/S2213-2600(14)70017-7.
28. Gingo M.R., Morris A., Crothers K. Human immunodeficiency virus-associated obstructive lung diseases. Clin. Chest Med. 2013; 34 (2): 273-282. https://doi.org/10.1016/j.ccm.2013.02.002.
29. Di Stefano A., Dossena F., Gnemmi I. et al. Decreased humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease. Respir. Res. 2022; 23 (1): 200. https://doi.org/10.1186/s12931-022-02125-3.
30. Чучалин А.Г., Цеймах И.Я., Момот А.П. и др. Изменения системных воспалительных и гемостатических реакций у больных с обострением хронической обструктивной болезни легких с сопутствующими хронической сердечной недостаточностью и ожирением. Пульмонология. 2014; (6): 25-32. https://doi.org/10.18093/0869-0189-2014-0-6-25-32.
31. Auld S.C., Kornfeld H., Maenetje P. et al. Pulmonary restriction predicts long-term pulmonary impairment in people with HIV and tuberculosis. BMC Pulm. Med. 2021; 21 (1): 19. https://doi.org/10.1186/s12890-020-01368-4.
32. Ханин А.Л., Кравец С.Л. Хроническая обструктивная болезнь легких и туберкулез: актуальная проблема в реальной практике (обзор литературы). Вестник современной клинической медицины. 2017 (6): 60-70. https://doi.org/10.20969/vskm.2017.10(6).60-70.
33. Singhvi D., Bon J., Morris A. Obstructive lung disease in HIV-phenotypes and pathogenesis. Curr. HIV/AIDS Rep. 2019; 16 (4): 359-369. https://doi.org/10.1007/s11904-019-00456-3.
34. Chimukangara B., Lessells R.J., Rhee S.Y. et al. Trends in pretreatment HIV-1 drug resistance in antiretroviral therapy-naive adults in South Africa, 2000-2016: a pooled sequence analysis. EClinicalMedicine. 2019; 9: 26-34. https://doi.org/10.1016/j.eclinm.2019.03.006.
35. Triplett M., Attia E.F., Akgyun K.M. et al. A low CD4/CD8 ratio in peripheral blood is associated with pulmonary emphysema in HIV. PLoS One. 2017; 12 (1): e0170857. https://doi.org/10.1371/journal.pone.0170857.
36. Collier D.A., Monit C., Gupta R.K. The impact of HIV-1 drug escape on the global treatment landscape. Cell Host Microbe. 2019; 26 (1): 48-60. https://doi.org/10.1016/j.chom.2019.06.010.
37. Drain P.K., Dorward J., Violette L.R. et al. Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial. Lancet HIV. 2020; 7 (4): e229-237. https://doi.org/10.1016/S2352-3018(19)30402-3.
38. Sadiq U., Shrestha U., Guzman N. Prevention of opportunistic infections in HIV/AIDS. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK513345
39. Nacher M., Huber F., Adriouch L. et al. Temporal trend of the proportion of patients presenting with advanced HIV in French Guiana: stuck on the asymptote? BMC Res. Notes. 2018; 11 (1): 831. https://doi.org/10.1186/s13104-018-3944-y.